Blepharitis

Latest News

Image Credit: © ohishift - stock.adobe.com
Safety, efficacy of lotilaner ophthalmic solution for Demodex blepharitis treatment

March 31st 2023

Though there is no current FDA-approved treatment, lotilaner ophthalmic solution, 0.25%, is the first drug designed to treat and target the underlying cause of Demodex blepharitis.

SECO 2023: Drugs of the future
SECO 2023: Drugs of the future

March 2nd 2023

Eye care therapies on the move: What’s in the pipeline
Eye care therapies on the move: What’s in the pipeline

September 16th 2022

Effective treatments for presbyopia, myopia, demodex
Effective treatments for presbyopia, myopia, demodex

March 12th 2022

Protect patients’ eyes by encouraging a three-step ocular wellness regimen
Protect patients’ eyes by encouraging a three-step ocular wellness regimen

October 9th 2020

Video Interviews
Latest CME Events & Activities

(CME Credit) Community Practice Connections™: Expert Approaches in Cataract Surgery – Managing Advances in Techniques and Technologies With an Updated Armamentarium

View More

(COPE Credit) Community Practice Connections™: Expert Approaches in Cataract Surgery – Managing Advances in Techniques and Technologies With an Updated Armamentarium

View More

(CME/CNE Credit) Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED

View More

(COPE Credit) Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED

View More

(COPE Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(CME Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

Shared Perspectives in Managing Presbyopia – Understanding a New Paradigm for Optimizing Quality of Life

View More

Perfecting Co-Management of Glaucoma – Utilizing Development in the Spectrum of Treatment Options

View More

Community Practice Connections™: 2nd Annual Optometry Times™ EyeCon

View More

Expert Insights in Geographic Atrophy with Transformative Care on the Horizon – Understanding the Complement System as a Target for Treatment

View More

EnVision Summit

February 16–19, 2024

Register Now!

Vance Thompson Vision

4 dates: Saturday, February 24, Friday, September 20, Friday, October 11, and Friday, October 25

Register Now!

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(CME Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations

View More

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment

View More

(COPE Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment

View More

18th Annual Controversies in Modern Eye Care

May 4, 2024

Register Now!

(COPE Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations

View More

(CME Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis

View More

(COPE Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis

View More

2nd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between

May 18-19, 2024

Register Now!

(CME Credit) Virtual Case Studies™ in Cataract Surgery: Selecting Surgical Techniques and Preventing Intra-Operative Complications

View More

Neurotrophic Keratitis Management: How Early Intervention Can Make a Difference

View More

(COPE Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention

View More

(CME Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention

View More

1st Annual IKA Keratoconus Symposium: Front to Back and Everything In Between

View More

17th Annual Controversies in Modern Eye Care

View More

More News

© 2023 MJH Life Sciences

All rights reserved.